This is great news @pfeifer1982
I like how you can compare the changes to the trial over time via a side by side comparison (see link below)
https://clinicaltrials.gov/ct2/history/NCT04537351?A=3&B=4&C=Side-by-Side#StudyPageTop
Quite a big change looking at all the updates and recruitment centers.
Looking at a chart of the incidence of ARDS in the general population (below), a rate of about 15 per 100,000 seems quite common.
Recruitment shouldn't take too long now, can't wait to see the results! especially after seeing the positive clinical trial results coming out from other similar trials (and more results to come soon).
Ann: Cynata Expands trial in COVID-19 & Respiratory Failure, page-169
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $40.41M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.5¢ | $11.57K | 49.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 100000 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 7426 | 1 |
View Market Depth
| Last trade - 15.43pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
-0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.5¢ | 23.0¢ | 10710 | ||
| Last updated 15.01pm 10/05/2024 ? | |||||
| CYP (ASX) Chart |